April 24, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Carna Biosciences and CrystalGenomics to Collaborate in Drug Candidate Development
 

Tokyo, June 10, 2004 (JCN) - Carna Biosciences announced on June 9 that it has agreed with Korean pharmaceutical company CrystalGenomics to collaborate in the field of drug discovery.

Under this partnership, the two companies will jointly research and develop candidate compounds for new drugs by making full use of each's expertise.

The two companies will focus on the treatments of cancer, articular rheumatism and atherosclerosis.

By Aki Tsukioka Contributor

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Carna Biosciences Inc. News  
  Carna Biosciences, Enamine to Collaborate in Research on Kinase  (May 18, 2006)
  Carna Biosciences, Enamine to Collaborate in Research on Kinase  (May 18, 2006)
  Carna Biosciences, ChemDiv to Collaborate in Creating and Marketing Annotated Kinase-focused Library  (Mar 31, 2006)
  Ginkgo Biomedical Research Institute, Carna Biosciences, CrystalGenomics to Collaborate in New Cancer Drug Development  (Mar 16, 2006)
  Carna Biosciences, CrystalGenomics, Rigel Pharmaceuticals Sign Service Agreement for X-ray Crystal Structure Analysis  (June 22, 2005)
  Fujirebio, Carna Biosciences to Co-develop Kinase Assay-related Products  (Oct 6, 2004)
  Carna Biosciences and CrystalGenomics to Collaborate in Drug Candidate Development  (June 10, 2004)
  Myristoyl Protein Directly Linked to Protein-protein Interaction: Riken and Carna Biosciences  (Feb 16, 2004)



 Recent  Drugs & OTC News   
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)
Dainippon Screen Launches High-speed Three-dimensional Cell Culture Scanner (Aug 8, 2013)
Daiichi Sankyo Expands Collaborative Drug Discovery Program to Germany, Switzerland, and Austria (Aug 1, 2013)
Takara Bio to Distribute ZENOAQ's Cell Cryopreservation Medium in Japan, Europe, and North America (July 26, 2013)
Takara Bio launches Nippi's iMatrix-511 Worldwide (July 12, 2013)
Furukawa Electric Develops Quartz Dot Test Kit to Detect Acanthamoeba (July 10, 2013)

More Drugs & OTC news...

 Recent  Drugs & OTC News   
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)
Dainippon Screen Launches High-speed Three-dimensional Cell Culture Scanner (Aug 8, 2013)
Daiichi Sankyo Expands Collaborative Drug Discovery Program to Germany, Switzerland, and Austria (Aug 1, 2013)
Takara Bio to Distribute ZENOAQ's Cell Cryopreservation Medium in Japan, Europe, and North America (July 26, 2013)
Takara Bio launches Nippi's iMatrix-511 Worldwide (July 12, 2013)
Furukawa Electric Develops Quartz Dot Test Kit to Detect Acanthamoeba (July 10, 2013)

More Drugs & OTC news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)